Hyperthyroidism overview: Difference between revisions
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
''Hyperthyroidism'' is the clinical [[syndrome]] caused by an excess of circulating free [[thyroxine]] (T4) or free [[triiodothyronine]] (T3), or both. | ''Hyperthyroidism'' is the clinical [[syndrome]] caused by an excess of circulating free [[thyroxine]] (T4) or free [[triiodothyronine]] (T3), or both. | ||
==Diagnosis== | |||
===Physical Examination=== | |||
Minor ocular signs, which may be present in any type of hyperthyroidism, are eyelid retraction ("stare") and lid-lag. These "fear-like" eye-signs result from thyroid hormone's exacerbation of the action of norepinephrine. In hyperthyroid ''stare'' ([[Dalrymple sign]]) the eyelids are retracted upward more than normal (the normal position is at the superior corneoscleral limbus, where the "white" of the eye begins at the upper border of the iris). In lid-lag ([[von Graefe's sign]]), when the patient tracks an object downward with their eyes, the eyelid fails to follow the downward moving iris, and the same type of upper globe exposure which is seen with lid retraction occurs, temporarily. These signs disappear with treatment of the hyperthyroidism, or treatment by certain anti-adrenergic drugs. | |||
===Laboratory Findings=== | |||
A diagnosis is suspected through blood tests, by measuring the level of [[thyroid-stimulating hormone]] (TSH) in the blood. A low TSH (the job of TSH taken over by thyroid-stimulating immunoglobulin [TSI] that act like TSH) indicates increased levels of T4 and/or T3 in the blood. Measuring specific [[antibody|antibodies]], such as anti-TSH-receptor antibodies in Graves' disease, may contribute to the diagnosis. | |||
===Other Imaging Findings=== | |||
In all patients with hyperthyroxinemia, [[scintigraphy]] is required in order to distinguish true hyperthyroidism from thyroiditis. | |||
==Treatment== | |||
===Medical Therapy=== | |||
The major and generally accepted modalities for treatment of hyperthyroidism in humans involve initial temporary use of suppressive thyrostatics medication, and possibly later use of permanent surgical or radioisotope therapy. All approaches may cause under active thyroid function (hypothyroidism) which is easily managed with [[levothyroxine]] supplementation. | |||
===Surgery=== | |||
Surgery as an option predates the use of the less invasive radioisotope therapy, but is still required in cases where the thyroid gland is enlarged and causing compression to the neck structures, or the underlying cause of the hyperthyroidism may be cancerous in origin. | |||
==References== | ==References== | ||
Revision as of 20:53, 31 January 2013
|
Hyperthyroidism Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Hyperthyroidism is the clinical syndrome caused by an excess of circulating free thyroxine (T4) or free triiodothyronine (T3), or both.
Diagnosis
Physical Examination
Minor ocular signs, which may be present in any type of hyperthyroidism, are eyelid retraction ("stare") and lid-lag. These "fear-like" eye-signs result from thyroid hormone's exacerbation of the action of norepinephrine. In hyperthyroid stare (Dalrymple sign) the eyelids are retracted upward more than normal (the normal position is at the superior corneoscleral limbus, where the "white" of the eye begins at the upper border of the iris). In lid-lag (von Graefe's sign), when the patient tracks an object downward with their eyes, the eyelid fails to follow the downward moving iris, and the same type of upper globe exposure which is seen with lid retraction occurs, temporarily. These signs disappear with treatment of the hyperthyroidism, or treatment by certain anti-adrenergic drugs.
Laboratory Findings
A diagnosis is suspected through blood tests, by measuring the level of thyroid-stimulating hormone (TSH) in the blood. A low TSH (the job of TSH taken over by thyroid-stimulating immunoglobulin [TSI] that act like TSH) indicates increased levels of T4 and/or T3 in the blood. Measuring specific antibodies, such as anti-TSH-receptor antibodies in Graves' disease, may contribute to the diagnosis.
Other Imaging Findings
In all patients with hyperthyroxinemia, scintigraphy is required in order to distinguish true hyperthyroidism from thyroiditis.
Treatment
Medical Therapy
The major and generally accepted modalities for treatment of hyperthyroidism in humans involve initial temporary use of suppressive thyrostatics medication, and possibly later use of permanent surgical or radioisotope therapy. All approaches may cause under active thyroid function (hypothyroidism) which is easily managed with levothyroxine supplementation.
Surgery
Surgery as an option predates the use of the less invasive radioisotope therapy, but is still required in cases where the thyroid gland is enlarged and causing compression to the neck structures, or the underlying cause of the hyperthyroidism may be cancerous in origin.